iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for the treatment of cancer. With a strong pipeline and a commitment to leveraging the potential of the immune system, iTeos has the potential to make a significant impact in the field of oncology.
